Donna M. Hacek

2.8k total citations
37 papers, 2.1k citations indexed

About

Donna M. Hacek is a scholar working on Infectious Diseases, Clinical Biochemistry and Epidemiology. According to data from OpenAlex, Donna M. Hacek has authored 37 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 19 papers in Clinical Biochemistry and 12 papers in Epidemiology. Recurrent topics in Donna M. Hacek's work include Antimicrobial Resistance in Staphylococcus (19 papers), Bacterial Identification and Susceptibility Testing (19 papers) and Streptococcal Infections and Treatments (6 papers). Donna M. Hacek is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (19 papers), Bacterial Identification and Susceptibility Testing (19 papers) and Streptococcal Infections and Treatments (6 papers). Donna M. Hacek collaborates with scholars based in United States, United Kingdom and Czechia. Donna M. Hacek's co-authors include Lance R. Peterson, Ari Robicsek, Suzanne M. Paule, Richard B. Thomson, Gary A. Noskin, Karen L. Kaul, Adrienne Fisher, William E. Trick, Teresa Zembower and Mary G. Lankford and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Donna M. Hacek

37 papers receiving 2.0k citations

Peers

Countries citing papers authored by Donna M. Hacek

Since Specialization

Citations

This map shows the geographic impact of Donna M. Hacek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna M. Hacek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna M. Hacek more than expected).

Fields of papers citing papers by Donna M. Hacek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna M. Hacek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna M. Hacek. The network helps show where Donna M. Hacek may publish in the future.

Co-authorship network of co-authors of Donna M. Hacek

This figure shows the co-authorship network connecting the top 25 collaborators of Donna M. Hacek. A scholar is included among the top collaborators of Donna M. Hacek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna M. Hacek. Donna M. Hacek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dose-Ranging Study To Assess the Application of Intranasal 2% Mupirocin Calcium Ointment To Eradicate Staphylococcus aureus Nasal Colonization 2013 ·Surgical Infections ·Maitry S. Mehta, Donna M. Hacek, (unknown), Connie Price, Lance R. Peterson	11
2	Preventing Contamination of Central Venous Catheter Valves with the Use of an Alcohol-based Disinfecting Cap 2012 ·American Journal of Infection Control ·Marc‐Oliver Wright, (unknown), (unknown), (unknown), Donna M. Hacek, (unknown), Lance R. Peterson	3
3	Significant impact of terminal room cleaning with bleach on reducing nosocomial Clostridium difficile 2010 ·American Journal of Infection Control ·Donna M. Hacek, (unknown), Adrienne Fisher, Ari Robicsek, Lance R. Peterson	69
4	Management of a multidrug-resistant Acinetobacter baumannii outbreak in an intensive care unit using novel environmental disinfection: A 38-month report 2009 ·American Journal of Infection Control ·(unknown), John E. Franke, Donna M. Hacek, Richard B. Thomson, Ari Robicsek, Lance R. Peterson	65
5	Chromogenic Media vs Real-Time PCR for Nasal Surveillance of Methicillin-ResistantStaphylococcus aureus 2009 ·American Journal of Clinical Pathology ·Suzanne M. Paule, Maitry S. Mehta, Donna M. Hacek, (unknown), Ari Robicsek, Lance R. Peterson	46
6	Staphylococcus aureus Nasal Decolonization in Joint Replacement Surgery Reduces Infection 2008 ·Clinical Orthopaedics and Related Research ·Donna M. Hacek, William Robb, Suzanne M. Paule, James C. Kudrna, Van P. Stamos, Lance R. Peterson	122
7	Universal Surveillance for Methicillin-Resistant Staphylococcus aureus in 3 Affiliated Hospitals 2008 ·Annals of Internal Medicine ·Ari Robicsek, Jennifer L. Beaumont, Suzanne M. Paule, Donna M. Hacek, Richard B. Thomson, Karen L. Kaul, Peggy King, Lance R. Peterson	309
8	Case Study: An MRSA Intervention at Evanston Northwestern Healthcare 2007 ·The Joint Commission Journal on Quality and Patient Safety ·Lance R. Peterson, Donna M. Hacek, Ari Robicsek	42
9	Detection of Toxigenic Clostridium difficile in Stool Samples by Real-Time Polymerase Chain Reaction for the Diagnosis of C. difficile-Associated Diarrhea 2007 ·Clinical Infectious Diseases ·Lance R. Peterson, (unknown), Suzanne M. Paule, Donna M. Hacek, Ari Robicsek, Richard B. Thomson, Karen L. Kaul	165
10	Direct Detection of Staphylococcus aureus from Adult and Neonate Nasal Swab Specimens Using Real-Time Polymerase Chain Reaction 2004 ·Journal of Molecular Diagnostics ·Suzanne M. Paule, (unknown), Donna M. Hacek, Adrienne Fisher, Richard B. Thomson, Karen L. Kaul, Lance R. Peterson	67
11	Improving Patient Safety by Repeating (Read-Back) Telephone Reports of Critical Information 2004 ·American Journal of Clinical Pathology ·Joan Barenfanger, Robert L. Sautter, (unknown), Stephen M. Collins, Donna M. Hacek, Lance R. Peterson	63
12	Computer-Assisted Surveillance for Detecting Clonal Outbreaks of Nosocomial Infection 2004 ·Journal of Clinical Microbiology ·Donna M. Hacek, Ralph L. Cordell, Gary A. Noskin, Lance R. Peterson	25
13	An Outbreak of Bloodstream Infections in an Outpatient Hemodialysis Center 2002 ·Infection Control and Hospital Epidemiology ·Connie Price, Donna M. Hacek, Gary A. Noskin, Lance R. Peterson	21
14	Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f β-lactamase (SME-1) in the United States: results from the MYSTIC Programme 2001 ·Diagnostic Microbiology and Infectious Disease ·Ana Cristina Gales, Douglas J. Biedenbach, Patricia Winokur, Donna M. Hacek, Michael A. Pfaller, Ronald N. Jones	31
15	Contamination of the Clinical Microbiology Laboratory with Vancomycin-Resistant Enterococci and Multidrug- Resistant Enterobacteriaceae : Implications for Hospital and Laboratory Workers 2001 ·Journal of Clinical Microbiology ·Stephen M. Collins, Donna M. Hacek, (unknown), (unknown), Gary A. Noskin, Lance R. Peterson	10
16	Medical and Economic Benefit of a Comprehensive Infection Control Program That Includes Routine Determination of Microbial Clonality 1999 ·American Journal of Clinical Pathology ·Donna M. Hacek, (unknown), Gary A. Noskin, (unknown), Boris E. Reisberg, Lance R. Peterson	55
17	Highly Reproducible Bactericidal Activity Test Results by Using a Modified National Committee for Clinical Laboratory Standards Broth Macrodilution Technique 1999 ·Journal of Clinical Microbiology ·Donna M. Hacek, (unknown), Lance R. Peterson	45
18	Effects of incubation time and buffer concentration on in vitro activities of antifungal agents against Candida albicans 1997 ·Journal of Clinical Microbiology ·(unknown), Gary A. Noskin, Donna M. Hacek, Arlene A. Obias, Lance R. Peterson	25
19	Molecular typing for investigating an outbreak of Candida krusei 1996 ·Diagnostic Microbiology and Infectious Disease ·Gary A. Noskin, Jenny Lee, Donna M. Hacek, Michael Postelnick, Boris E. Reisberg, Valentina Stosor, Sigmund A. Weitzman, Lance R. Peterson	15
20	Successful Treatment of Persistent Bacteremia due to Vancomycin-Resistant, Ampicillin-Resistant Enterococcus faecium 1995 ·Microbial Drug Resistance ·(unknown), Gary A. Noskin, Donna M. Hacek, Lance R. Peterson	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact